Benjamin P Fairfax

19PUBLICATIONS
158CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)Gene expression (incl. microarray and other genome-wide approaches)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Nov 14, 2025
Identification of conserved immune-related adverse event risk factors and clinical outcomes in a pan-immunotherapy data mart.

David F Lamparter, Virginia C Schmid, Rajat Mohindra

|Nov 06, 2025
The immunomodulatory role of human cytomegalovirus in cancer in the era of checkpoint immunotherapy.

Julia Bremke, Cecilia Jay, Martin Little

|Sep 29, 2025
Genetic determinants of monocyte splicing are enriched for disease susceptibility loci.

Isar Nassiri, James J Gilchrist, Orion Tong

|Jul 25, 2025
Defining the genetic determinants of CD8+ T cell receptor repertoire in the context of immune checkpoint blockade.

Esther S Ng, Gusztav Milotay, Orion Tong

|Apr 24, 2025
CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade.

Gusztav Milotay, Martin Little, Robert A Watson

|Feb 06, 2025
Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanisms.

Shivan Sivakumar, Ashwin Jainarayanan, Edward Arbe-Barnes

Pageof 4

Frequent Collaborators

6 joint publications

Orion Tong

6 joint publications

Julian C Knight

5 joint publications

James J Gilchrist

5 joint publications

Mark R Middleton